CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Cash flows from operating activities
Net income (loss)	$ 14,581	$ (19,615)	$ 22,566	$ (47,036)
Adjustments to reconcile net income (loss) to net cash used in operating activities
Depreciation and amortization	29,779	21,642	56,846	43,941
(Gain) loss on disposal of property and equipment and divestitures			(2,384)	2,236
Equity in losses of unconsolidated entities	229		358
Bad debt expense (recovery)			1,263	(381)
Amortization of debt issuance costs	100	200	417	344
Inventory write-downs	300	100	189	82
Equity-based compensation			7,219	3,946
Bargain purchase gain	(5,607)		(17,041)
Unrealized loss on short-term investment			40	1,169
Other operating items, net			(478)	(139)
Changes in operating assets and liabilities
Accounts receivable			(89,653)	(19,054)
Prepaid expenses and other assets			5,620	(11,044)
Accounts payable and accrued liabilities			7,570	14,497
Net cash used in operating activities			(7,468)	(11,439)
Cash flows from investing activities
Purchase of property and equipment			(30,976)	(13,451)
Investment in note receivable				(1,101)
Purchase of equity method investments			(4,267)	(2,200)
Collection of note receivable			184
Distribution from cost method investment			60	120
Acquisitions, net of cash and restricted cash received			5,857
Proceeds received from sales of property and equipment			17,683	5,141
Other			(429)
Net cash used in investing activities			(11,888)	(11,491)
Cash flows from financing activities
Borrowings from revolving line of credit			30,000
Payments on revolving line of credit			(30,000)
Payments on long-term debt			(18,780)
Payments of finance lease obligations			(103)	(156)
Payment of debt issuance costs			(2,144)
Proceeds from share issuance			25	29
Distributions to noncontrolling interests				(1,074)
Repurchase of common stock			(19,695)	(1,206)
Net cash used in financing activities			(40,697)	(2,407)
Effect of exchange rate changes on cash			(6)	20
Net decrease in cash and cash equivalents			(60,059)	(25,317)
Cash and cash equivalents, beginning of period			85,801	169,039	$ 169,039
Cash and cash equivalents, end of period	$ 25,742	$ 143,722	25,742	143,722	$ 85,801
Supplemental cash flow disclosure:
Cash paid for interest			817	741
Cash refunds received for income taxes, net			(497)	(962)
Supplemental disclosure of noncash investing activities:
Issuance of shares for acquisitions			35,854
Conversion of notes receivable to equity-method investment			4,442
Capital expenditures included in accounts payable and accrued liabilities			$ 20,214	$ 6,038